Finance

Lists
LMAT:NASDAQ
LeMaitre Vascular Inc
$73.61
-1.67%
(-1.25) 1D
$73.61
0.00% (0.00)
After hours
Closed: Nov 20, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LMAT...
Open
$74.34
High
$76.44
Low
$73.44
Mkt. cap
1.68B
Avg. vol.
275.24K
Volume
313.55K
Dividend
1.36%
Quarterly dividend
$0.25
Ex-dividend date
Nov 19, 2026
P/E ratio
27.21
52-wk high
$118.01
52-wk low
$73.44
EPS
$2.71
Beta
0.51
Shares outstanding
22.88M
No. of employees
651
Open
$74.34
High
$76.44
Low
$73.44
Mkt. cap
1.68B
Avg. vol.
275.24K
Volume
313.55K
Dividend
1.36%
Quarterly dividend
$0.25
Ex-dividend date
Nov 19, 2026
P/E ratio
27.21
52-wk high
$118.01
52-wk low
$73.44
EPS
$2.71
Beta
0.51
Shares outstanding
22.88M
No. of employees
651
News stories
From web sources and news partners
About LeMaitre Vascular Inc
CEOGeorge W Lemaitre
Employees651
Founded1983
HeadquartersBurlington, Massachusetts, United States
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 5 analysts giving stock ratings to LMAT in the past 3 months
Buy
Buy
3
Hold
2
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for LMAT in the last 3 months.
Highest
Current $73.61
$110.00 (+49.44%)
Average
$98.00 (+33.13%)
Lowest
$86.00 (+16.83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Petusky
Barrington
Buy
Maintained
$91.00
+23.6%
11/05/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
$105.00
+42.6%
11/05/2026
Nathan Treybeck
Wells Fargo
Hold
Maintained
$86.00
+16.8%
11/05/2026
Daniel Stauder
Citizens JMP
Buy
Maintained
$110.00
+49.4%
11/05/2026
Brett Fishbin
KeyBanc
Hold
Maintained
-
-
11/05/2026
Keith Hinton
Freedom Capital Markets
Hold
Maintained
$81.00
+10%
08/14/2026
Unknown Analyst
Wells Fargo
Hold
Reiterated
$94.00
+27.7%
08/05/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$135.00
+83.4%
05/06/2026
James Sidoti
Sidoti
Buy
Maintained
$132.00
+79.3%
05/06/2026
Kyle Bauser
Roth MKM
Buy
Reiterated
$117.00
+58.9%
02/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
64.45M
66.55M
70.38M
67.97M
Cost of goods sold
18.26M
18.16M
19.62M
21.96M
Cost of revenue
18.26M
18.16M
19.62M
21.96M
Research and development expenses
3.53M
4.06M
4.85M
4.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.82M
26.56M
25.52M
26.99M
Operating expense
27.36M
30.62M
30.36M
31.71M
Total operating expenses
45.62M
48.78M
49.98M
53.68M
Operating income
18.83M
17.78M
20.40M
14.30M
Other non operating income
-46.00K
-127.00K
-294.00K
-82.00K
EBT including unusual items
20.30M
19.67M
22.19M
19.67M
EBT excluding unusual items
20.84M
19.67M
22.19M
16.27M
Income tax expense
4.72M
3.99M
5.14M
4.65M
Effective tax rate
23.24%
20.30%
23.16%
23.64%
Other operating expenses
-
-
-
-
Net income
15.58M
15.68M
17.05M
15.02M
Net profit margin
24.18%
23.56%
24.22%
22.10%
Earnings per share
0.68
0.68
0.74
0.65
Interest and investment income
3.35M
3.32M
3.39M
3.36M
Interest expense
-1.30M
-1.30M
-1.30M
-1.30M
Net interest expenses
2.05M
2.02M
2.08M
2.06M
Depreciation and amortization charges
-
-
-
-
EBITDA
21.44M
20.40M
23.06M
17.18M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps